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Abstract 
We characterised cognitive function in two metabolic diseases.  MPS-IVa (Morquio) and  
Tyrosinemia Type III individuals were assessed using tasks of attention, language and oculomotor 
function.  MPS-IVa individuals were slower in visual search, but the display size effects were normal 
and slowing was not due to long reaction times (ruling out slow item processing or distraction).  
Maintaining gaze in an oculomotor task was difficult.  Results implicated sustained attention and task 
initiation or response processing.  Shifting attention, accumulating evidence and selecting targets were 
unaffected. Visual search was also slowed in Tyrosinemia Type III and patterns in visual search and 
fixation tasks pointed to sustained attention impairments, although there were differences from MPS-
IVa.  Language was impaired in Tyrosinemia Type III but not MPS-IVa.  Metabolic diseases produced 
selective cognitive effects.  Our results, incorporating new methods for developmental data and model 
selection, illustrate how cognitive data can contribute to understanding function in biochemical brain 
systems.     
Keywords: Morquio, MPS-IVa, Tyrosinemia, inherited metabolic disease, language, 
attention, developmental disorder 
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Markers of cognitive function in individuals with mild metabolic disease:  Morquio 
Syndrome and Tyrosinemia Type III  
Inherited metabolic diseases (IMDs) are large and heterogeneous class of genetic disorders that 
are caused by dysfunction within a single pathway of intermediary metabolism. In these diseases the 
dysfunction of metabolic enzymes leads to the accumulation of metabolites, which are often toxic, 
disrupting the normal development of multiple systems. The severity of symptoms associated with 
IMDs can vary widely. Mild symptoms can include physiological abnormalities such as skeletal 
dysplasia and impaired endurance (Davison, Kearney, & Horton, 2013; Wraith, 2006). Severe 
consequences include mental retardation, central nervous system (CNS) complications, and reduced life 
expectancy (Bendadi et al., 2014; De Laet et al., 2011; Masurel-Paulet et al., 2008; Thimm et al., 2011, 
2012). Research into the cognitive impact of IMDs has largely been limited to standardised intelligence 
tests, achievement tests and adaptive behaviour scales (Bax & Colville, 1995; Biernacka, Jakubowska-
Winecka, & Tylki-Szymanska, 2010; Davison et al., 2013; Shapiro et al., 2009).  These do not generally 
allow impairments in specific cognitive domains to be characterised or tracked over time  (Martin et al., 
2008). In the current study we present results from two IMD groups, Morquio syndrome and 
Tyrosinemia type III, where cognitive impairments have been considered mild (using standardised 
tests).  We compare individuals with Morquio syndrome and Tyrosinemia type III to typically 
developing controls (Thomas, Annaz, & Ansari, 2009) to evaluate affected and preserved cognitive 
abilities in the domains of language, attention and oculomotor control. 
 
Morquio Syndrome (MPS-IVa , OMIM 253000)  
Morquio syndrome (MPS-IVa) is lysosomal storage disorder that is caused by the deficiency of 
the lysosomal enzyme N-acetylgalactosamine-6-sulfase (GALNS, EC 3.1.6.4; encoded by GALNS gene 
at 16q24.3) which has a role in degradation of the glycosaminoglycans (GAG) keratan sulphate and 
chondroitin-6-sulfate (Neufeld & Muenzer, 2001; Wraith, 2006). Both keratan sulphate and 
chondroitin-6-sulfate are essential constituents of connective tissue, including cartilage and vessel 
walls. The accumulation of these two GAGs leads to a classic phenotype defined by severe skeletal 
dysplasia, hip dysplasia, marked short stature, genu valgum, and cornea clouding (Hendriksz et al., 
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2013; Wraith, 2006). Treatments to reduce substrate burden in MPS-IVa include enzyme replacement 
therapy (ERT) and haematopoietic stem cell transplantation (HSCT), which alleviate the majority of the 
skeletal and coronary complications. 
In contrast to other lysosomal storage disorders (e.g. Hurler-Scheie syndrome, Hunter’s 
syndrome, Niemann-Pick Type C), Individuals with MPS-IVa have not typically been reported to have 
neurological or neurocognitive impairments (Dvorak-Ewell et al., 2010; Wraith, 2006) and 
neuroimaging results usually find no neuroanatomical abnormalities (Koto, Horwitz, Suzuki, Tiffany, & 
Suzuki, 1978). However, recent neurocognitive findings (Davison et al., 2013) from eight individuals 
with MPS-IVa (aged 5 -17 years) suggested that mild/borderline cognitive impairments do exist. Age 
appropriate standardised tests (e.g. WASI, WISC) revealed full scale IQ scores either in the lower 
average range (80 – 90), borderline range (70 – 80), or extreme low range (<70) in four individuals. The 
remaining four individuals had normal Full Scale IQ (85 – 115). Attention problems were reported by 
the majority of parents using the Child Behavioural Checklist.  
Mild cognitive impairments were supported by MRS findings in the same study. In three 
individuals with cognitive impairments there was a correlation between white matter metabolite 
concentrations (N-acetylaspartate) and cognitive indices. In addition, MRI findings revealed 
neuroanatomical abnormalities in more than half the MPS-IVa individuals. These included mild 
asymmetry of the lateral ventricles, prominent perivascular spaces and high signal white matter areas of 
the right frontal lobe.   Unlike the MRS findings, there was no correlation with cognitive indices, but 
this could be because the behavioural measures lacked sensitivity.  A formal assessment of attention is 
needed, especially in the context of the attentional difficulties reported by parents.   
Tyrosinemia Type III (T3, OMIM 276710) 
Tyrosine is an amino acid that is catabolised into fumarate and acetoacetate, both of which are 
important for gluconeogenesis and ketogenesis. Dysfunction at different points in this enzymatic 
pathway will lead to one of three identified hypertyrosinemia disorders: tyrosinemia types I to III, 
which result in the accumulation of plasma tyrosine levels and increased urine excretion of tyrosine 
(Chakrapani, Gissen, & Mckiernan, 2012).  Tyrosinemia type I is caused by a deficiency in 
fumarylacetoacetate hydrolase, the final enzyme in the tyrosine catabolic pathway. It leads to an 
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accumulation of highly toxic fumaryl- and maleylacetoacetate in the liver. This produces organ 
dysfunction and carcinogenesis, with hepatocellular carcinoma a frequent cause of death in childhood.  
Tyrosinemia type II, results from a defect in tyrosine transaminase, the first enzyme in the tyrosine 
pathway.  It affects the eyes and skin, but also mental development. Tyrosinemia type III (T3), the 
disease we are concerned with here, is caused by the deficiency of 4-hydroxyphenylpyruvate 
dioxygenase, the second enzyme in the pathway.  It causes extreme accumulation and increased 
excretion of tyrosine, but not the increase in the toxic metabolites associated with the later type I 
enzyme defect (Chakrapani et al., 2012; Scott, 2006). Treatment consists of a low-protein diet and 
administration of ascorbic acid to control tyrosine levels (Scott, 2006).   
T3 is the rarest of the three tyrosinemias and the effects of elevated concentrations of tyrosine in 
the central nervous system are not well established. Only 15 cases have been reported in the literature to 
date (Ellaway et al., 2001; Heylen et al., 2012; Szymanska et al., 2015). However, neurological and 
intellectual difficulties are commonly reported. Ellaway et al.’s (2001) review is the best description of 
cognitive functioning in 13 T3 individuals. Eight had neurological symptoms, such as developmental 
delay or mental retardation, attention deficit and behavioural disturbances, acute ataxia, tremor, 
hypotonia and absent deep tendon reflexes. The most common long-term complication was intellectual 
impairment (75% of individuals; Ellaway et al., 2001).  Ellaway et al. speculated that the intellectual 
impairments resulted from the neurotoxic effects of elevated tyrosine levels. Their results, however, 
were based on aggregated scores (e.g. e.g. Stanford-Binet, WISC, WASI), so a profile of specific 
cognitive impairments remains to be determined.  
Tyrosinemia type I is treated with 2-nitro-4-trifluromethylbenzoyl (NTBC), which makes treated 
type I an indirect window on T3.  Treatment stops tyrosine metabolism earlier and prevents the 
accumulation of toxic metabolites that cause liver cancer, but it also gives T1 individuals the same 
biochemical profile as T3, raising tyrosine concentrations.  T1 is a more common form of tyrosinemia 
and, in contrast to T3, more detailed reports of neurocognitive function exist (Bendadi et al., 2014; 
Thimm et al., 2011; Van Ginkel et al., 2016)  Different studies have documented lower IQ scores and 
specific language production and comprehension impairments in NTBC-treated T1 individuals 
(Bendadi et al., 2014; Thimm et al., 2012).  
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The most detailed assessment of cognitive function in T1 was recently reported by Van Ginkel et 
al.  (2016), measuring nineteen NTBC-treated individuals with both age-appropriate psychometric tests 
(e.g. WISC and WASI) and additional measures of executive functioning. Average IQ was lower 
(median 85: range 55 – 111) and there were specific working memory deficits (in reaction time and 
error rates). No differences in inhibition were found. The cognitive deficits from the T1/NTBC studies 
could be due to elevated levels of neurotoxic tyrosine, but they could also be a direct effect of NTBC 
(Van Ginkel et al., 2016).  Results from T3 can help to clarify this. 
Taken together, these findings (Bendadi et al., 2014; Ellaway et al., 2001; Thimm et al., 2012; Van 
Ginkel et al., 2016), give us some reason to predict cognitive impacts in tyrosinemia type III.  As with 
Morquio Syndrome, we will characterise the presence or absence of deficits across cognitive domains 
(language, attention and ocular-motor control) to show whether there is a homogeneous pattern, or 
selective deficits in particular areas. 
Patterns associated with functional deficits 
We probed the cognitive domains of attention, language and oculomotor control to see if deficits 
selectively affect different domains in different diseases.   Beyond this, some deficits predict 
characteristic patterns across domains. We distinguish deficits in processing speed, selective attention, 
sustained attention.   
A deficit of processing speed should be particularly evident in a simple RT task, where cognitive 
demands are minimized, allowing speed to be a primary influence on outcomes, but effects should be 
noted in all speed dependent tasks, including conjunction and feature search and saccade onset times.  
Slower processing speed should produce exaggerated effects of difficulty in tasks where the number of 
operations is manipulated explicitly, like conjunction search.   For the same reason, when dividing 
reaction times into quintiles, slower reaction times should show larger differences from controls than 
faster times, although there could be some difference even for faster times. 
A deficit of selective attention should impact conjunction search specifically, leading to increased 
effects for larger displays, without changing feature search times, simple reaction time or saccade 
onsets.  Larger differences should be noted in slower quintiles of the RT distribution for conjunction 
search only.   
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A deficit of sustained attention should lead to shorter times on target in the fixation task and more 
intrusive saccades.  It should also create a subset of longer reaction times in search tasks (due to 
distraction).  Faster reaction times, however, should not be different from controls. 
 
Methods  
Participants 
Morquio Syndrome (MPS IVa) and Tyrosinemia Type III (T3) 
Thirteen individuals with MPS-IVa (8 male; mean age: 9.59 years, range: 5.27 – 14.39 years) 
and eleven with tyrosinemia type III (3 male; mean age: 12.53 years, range: 4.40 – 19.58 years) were 
recruited at Birmingham Children’s Hospital, UK (demographics in Appendix 1). Diagnosis of MPS-
IVa was confirmed via genetic testing. All MPS-IVa individuals had a severe phenotype of the disease, 
but none had corneal clouding and none was ventilated. Tyrosinemia Type III was confirmed via 
genetic testing after elevated tyrosine levels were detected during newborn screening. All individuals 
were native English speakers.  A number were bilingual (see Appendix 1).  Both groups of children 
with disease were tested in 2012-13 at the Wellcome Trust Clinical Research Facility at the 
Birmingham Children’s Hospital. Consent was obtained from parents/guardians prior to testing. 
Typically Developing Controls (TD) 
Individuals with metabolic disease were compared to typically developing controls (TD), using 
a developmental trajectory approach (e.g. Thomas et al., 2009).  We tested a large sample of controls 
across a range of ages between 6 and 20 to establish the trajectory of typical development in each 
cognitive domain (Attention tasks N = 104, Language tasks N = 104, Oculomotor tasks N = 265).  Prior 
to testing, informed consent was taken from undergraduate student participants or from parents of child 
participants. 
Apparatus & Procedure 
Our battery of test took approximately 1 – 1.5 hours to complete, depending on ability and need 
for breaks.  
Attention and oculomotor tasks were created using Experiment Builder (SR Research Ltd., 
Mississauga, Ontario, Canada). Participants viewed stimuli from 60 cm on a 36 x 27 cm CRT-monitor 
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with a resolution of 1024 by 768 pixels and a refresh rate of 60Hz, producing a viewing area of 33.5° x 
25.5° (width x height) of visual angle. Reaction time (RT, measured in milliseconds, msec) for manual 
responses were recorded using a Cedrus button box (http://cedrus.com/). 
Eye movements were recorded via an EyeLink® 1000 Tower Mount (SR Research Ltd., 
Ontario, Canada). Eye position was measured using corneal reflection via an infrared camera. Head 
movement was minimized using a forehead and chin rest. Eye movements were calibrated to an 
accuracy of at least 1⁰ using a nine-point calibration array. Drift correction was employed before each 
trial. Participants were recalibrated if central fixation was inaccurately displayed. Saccade detection was 
based on default Eyelink 1000 settings (19-sample window): samples were classified as part of a 
saccade if eye velocity exceeded 22⁰/second and eye position changed more than 0.3
 ⁰, otherwise 
samples were classified as fixations. Prior to analysis, trials from all tasks were visually inspected to 
ensure that participants were engaged in the task and artefacts had been removed.  
Attention tasks 
Attention tasks included simple reaction time and visual search. We familiarised participants 
with the visual search targets (red ladybirds) by introducing them in the simple reaction time task, 
which was always presented first. 
Simple reaction time measured speed to respond to appearance of a visual target. Participants 
completed 20 trials where a red ladybird (5.5° x 7.5°) was presented in a box in one of the four 
quadrants around the centre (upper left, upper right, lower left, lower right; box size = 10° x 9°; 12° 
diagonal distance from screen centre). Quadrants were systematically probed in this task and in the eye-
movement tasks because regions of space can be affected by attention or eye-movement deficits (e.g. 
neglect, usually affecting attention to the left side of space, or vertical supranuclear gaze palsy, affecting 
vertical eye-movements).  The target appeared in each quadrant 5 times, with the order of the target 
locations randomised between participants. Each trial began with a centrally presented fixation cross (1° 
x 1°). After a variable delay of 1500–4000 ms the red ladybird target stimulus was presented in one of 
the four quadrants. Participants were instructed to respond with their preferred hand, using a single 
button press, as quickly as possible after the target appeared. The stimulus remained on the screen until 
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the participant made a response or for 3000 ms.  There was an inter-trial interval of 1000 ms prior to the 
presentation of the fixation cross for the following trial.   
  Visual search is a prototypical task of selective attention that has been studied 
extensively and used to motivate a number of influential models (Bundesen, Habekost, & Kyllingsbæk, 
2005; Moran, Zehetleitner, Muller, & Usher, 2013; Schwarz, 1993; Schwarz & Miller, 2016; A. 
Treisman & Gelade, 1980; A. Treisman & Sato, 1990; Verghese, 2001; Ward & McClelland, 1989; 
Wolfe, 2007). Our visual search task consisted of 3 feature search blocks and 3 conjunction search 
blocks. In all blocks participants indicated, with a yes/no button press, whether the red ladybird 
character was present. Feature search asked the participants to search for the red ladybird among a set of 
green ladybird distracters. The target was defined by colour only.  This means that the target typically 
appears to “pop out” regardless of the number of distractors.   Instead, conjunction search asked 
participants to search for a red ladybird among green ladybirds and red beetle distractors.  No single 
feature dimension defines the target (it is red AND a ladybird) and this typically means that items need 
to be searched more systematically, leading to longer reaction times for larger displays.  Each block 
contained 12 trials with 3 display sizes (4, 8, and 12 items). The target was present in half the trials in 
each block. Block order was randomised between participants. Search displays were created by dividing 
the screen into a 4 x 4 grid (each grid location = 8.5° x 6.5°). Search items (4° x 5° of visual angle) were 
randomly assigned to the 16 grid locations. Each item’s position was jittered by a random amount to 
make displays less regular  (x maximum ±2° and  y maximum ±1°).  For target-present conjunction 
trials one red beetle distractor was replaced with the target to ensure the number of red and green 
elements were equal. 
Each trial began with a centrally presented fixation cross (1000 ms), followed by the stimulus. 
Participants used a Cedrus button box to make a response (left button = target absent; right button = 
target present). Stimuli disappeared after a response or if no response was registered within 10 seconds. 
A blank screen was displayed (1000 ms) prior to the following trial. At the beginning of each block 
participants were informed of the block type (feature or conjunction). Targets and distractors were 
shown on screen and verbal instructions given by the experimenter. There were four practice trials with 
feedback, at the beginning of the experiment, to familiarise participants with the task.   
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We used response times for correct responses to calculate a mean visual search reaction time 
(or intercept). We also measured search efficiency, defined as the slope of RT change with increasing 
display size.  
Language tasks 
Measures of verbal production (Boston Naming Task or BNT; Kaplan, 2000) and 
comprehension (British Picture Vocabulary Scale or BPVS; Dunn et al., 1997) were used to assess 
children’s language abilities.  
The BNT is a 60-item picture naming test where items increase in difficulty, becoming 
increasingly infrequent and unfamiliar (e.g. trellis).  If a participant was unable to name an item, a 
semantic cue was offered.  A phonetic cue was provided if the semantic cue failed to produce a correct 
response. An item was counted as correct if the participant was able to name it with or without a 
semantic cue, and incorrect if the participant failed to produce the name or did so only after a phonetic 
cue. The test is stopped if participants make more than 5 consecutive errors. 
The BPVS is a receptive vocabulary test. Participants listen to a word and select a matching 
picture from four alternative line drawings.  There is no spoken response.  There were 14 sets of 12 
items, which, like the BNT, increase in difficulty because the targets are increasingly uncommon items. 
The test was stopped if there were eight or more errors on a single set.  
Oculomotor tasks 
Oculomotor function was tested using a fixation and pro-saccade task (Fischer & Weber, 2010; 
Klein, 2001; Munoz & Everling, 2004; Salman et al., 2006). 
Fixation Task 
Participants were asked to fixate a central target, look to the target when it moved to one of four 
possible non-central positions and then maintain their gaze until the target disappeared.  There were 20 
trials.  An elephant face target (1.5 ⁰ in size) appeared in the centre of the screen and then moved to a 
location 10⁰ to the left, right, above or below central fixation. Possible target locations were marked 
with small circles (0.5 ⁰ in size) to indicate where the target might appear. Trials began with the 
presentation of the target centrally for 1000 ms. The target disappeared and immediately reappeared (no 
gap or overlap) randomly at one of the four surrounding locations. The target remained at this location 
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for 5000ms and participants were asked to maintain fixation on the target until it disappeared.  A 3 x 3° 
box surrounding each target was defined as a region of interest (ROI) and fixations within the ROI were 
counted as fixations on the target. Dwell time was defined as the length of time participants maintained 
eye position within the target’s ROI (FixDwell). The frequency of intrusive saccades away from the 
target (greater than 2°) that moved the participant’s gaze outside the target ROI were also measured 
(FixSacc). 
Pro-saccade Task 
Participants viewed 48 trials where a target elephant face (1.5⁰ in size) randomly appeared at 
one of eight positions around a central starting position. The four locations from the fixation task were 
used (see above), along with four additional locations, closer to the centre (eccentricity = 5⁰). Each trial 
began with the stimulus displayed at the centre of the screen for a random amount of time between 1000 
and 2000ms. The stimulus then disappeared and reappeared at one of the possible target locations for 
1000ms without any gap or overlap. Participants were asked to look as quickly and accurately as 
possible directly at the target. There was no instruction to maintain fixation.   
To be included in the analysis, saccades had to start at the centre of the screen and the eye 
movement had to be toward the peripheral target. We measured the onset of the first movement toward 
the target and its peak velocity.  To simplify the presentation only data from targets at 10⁰, where the 
distance is greater, are presented here, but  data from closer targets did not change the pattern. 
Data Analysis 
Across tasks, reaction times that were greater than 3 SDs away from individual participant 
means were defined as outliers and removed.  Individuals with metabolic disease and typically 
developing (TD) control children were compared using a developmental trajectory approach (Thomas et 
al., 2009).   Developmental change was modelled as a linear or quadratic function of age. We were 
interested in differences in the rate of developmental change (differences in the slope of trajectories) 
and differences in absolute levels of performance (offsets between disease group and control 
trajectories). Data from our experimental tasks was fit using linear mixed effects models (LME, using 
the R package lme4) with fixed factors for Group, Age and, where appropriate, Condition (e.g. target 
location). A main effect of Group indicated an effect of disease across all ages, and a main effect of Age 
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indicated  age-related developmental change. Interactions between Group and Age indicated that 
disease modified the rate of developmental change. Akaike’s Information Criterion (AIC) was used to 
compare models (Burnham & Anderson, 2002).
1
  
The set of models we compare are familiar from more traditional analyses (e.g. ANOVA).  For 
example, in an experiment with factors of Age, Group and Condition, we start from a model whose 
most complex term is the three-way interaction Age X Group X Condition (this model will also contain 
all lower-level two-way interactions and main effects). We compare this to the set of simpler models 
that have one or more effects removed.  If a simpler model accounts for data as well as a complex 
model, the missing effects were not important.  Our final model includes only effects that are needed to 
account for the data.  The highest order model for each analysis, the one reduced models are derived 
from, is listed as the generating model along with models results in Appendix A.  Random effects 
structures for each analysis are also listed in Appendix A.  The list of model results includes the models 
closest to the minimum AIC model.  Models not listed were worse. 
We report results from a large sample of controls and a much smaller sample of individuals 
with metabolic disease, as is inevitable in the study of rare diseases.  This means that models that do not 
involve the Group term are largely determined by the data from normally developing control 
participants.  For each task, we initially model only data from typically developing controls to 
characterise normal development (e.g. to ask whether the effect of Age is absent, linear or quadratic).  
                                                     
1Model selection using AIC is different from p-values, but not difficult to understand. AIC is 
preferred for model comparison because, unlike p-values, AIC balances fit and the number of model 
parameters when choosing models.   In brief, better models produce smaller AIC values, but the 
absolute AIC values are not interpretable.  Instead, the change in AIC (∆AIC) between models is 
meaningful and captures the weight of evidence for each model (rather than being subject to a cut-off, 
like p-values).   Evidence for a model starts to be clear if the ∆AIC exceeds 2. If ∆AIC between the 
“best” model and alternative models is less than 2 then the two models are substantially equivalent. 
When ∆AIC is between 2 and 10 there is decreasing support for an alternative model.  A model with a 
∆AIC > 10 has essentially no support.  For models where the ∆AIC is less than 2, it is reasonable to 
favour the least complex model (i.e. model with fewest parameters/variables).   Favoured models 
contain terms that are important in accounting for data.  This is parallel to significant effects in an 
analysis using hypothesis testing.  For example, if a highly-rated model has a term for Group but no 
interaction, this is parallel to a significant main effect of Group and a non-significant interaction. 
Comparisons can be assisted by calculating Akaike weights (AICw; Burnham & Anderson, 
2002).  AICw expresses the relative probability that a model is the best in a particular set, considering 
only the models from that set. It measures the weight of evidence for the models being compared.  
When values are relatively equal across two or more models, they are all relatively good models of the 
data.  If one model has a high value and the others are low, there is a model that is clearly better. 
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Then, using the full dataset, we check interactions between terms in the best model for control data and 
Group (i.e. results from control and disease groups concentrate on evaluating the influence of the term 
for Group). 
Because of possible heterogeneity among individuals within each disease group we also 
compared individuals with disease to typically developing controls (TD).  The question was whether 
each individual was inside or outside the range of typically-developing values.  To define the range of 
typically developing values, 95% prediction intervals were defined at each age, setting a cutoff above 
and below the TD means.  Ninety-five percent of individual control values should fall between these 
points.  Cutoffs for each age were smoothed to a boundary that applied across ages by fitting a curve, 
separately, to the set of upper boundary points and then lower boundary points. This minimises the 
impact of idiosyncratic estimates, smoothing the boundary position across ages by borrowing 
information from adjacent age groups.  After defining limits, individuals with disease were compared to 
controls using the equivalent of z-scores, but using the upper or lower endpoints of the smoothed 
prediction intervals, rather than the noisier age-specific cuoffs. We label these zpi.2 
Results 
Table 1 summarises domains where Morquio (MPS-IVa) and Tyrosinemia (T3) individuals had 
difficulties (shaded in grey) and is based on the results described in more detail below.  The number of 
individuals who performed worse than the control mean, worse that 1 SD from the control mean and 
worse than 2 SD from the control mean are listed.  MPS-IVa individuals displayed clear deficits in 
sustained attention and non-decision aspects of selective attention tasks, e.g. the amount of time fixation 
could be maintained and reaction time intercepts in visual search. T3 individuals exhibited clear deficits 
in language tasks (BNT and BPVS). They also had problems with sustained attention that affected 
fixation and visual search  and modest slowing in simple reaction time.  
________________ 
Table 1 about here 
                                                     
2
 Specifically, for values above the mean,  = (!"#$% − '()*+(, -./))/1.96 and 3 =
4./)56$76/ , where !"#$%= upper boundary of the smoothed prediction interval; control mean = the mean 
predicted by smoothing control mean values; and 4./)56$76  = individual patient’s mean value. Values below 
the mean were calculated in the same way except the 95% prediction interval boundary (!"89:$%) used the lower 
boundary since boundaries were not necessarily symmetric. 
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________________ 
Attention - Simple Reaction Time Task 
Typically developing Controls (TD) 
Reaction times were log transformed because, as is often the case, the raw RT distribution was 
right-skewed and a log transform produced a more balanced distribution.  A model with a quadratic 
term for age was used because the developmental trajectory was curved, not linear (Figure 1). The best 
model included an effect of age, distinct trajectories for left and right locations and an interaction 
between location and age. Reaction times were slower to right targets.  The left/right difference in 
younger children was 51 msec and then decreased with age. The majority of developmental change 
occurred during the first years of development, with little change after age 12 (~300 msec over the 
range from 6 to 12 years).   
_________________ 
Figure 1 about here 
__________________ 
Morquio syndrome (MPS-IVa) 
RT means for MPS-IVa individuals are displayed in Figure 1a.  They were within the 
confidence limits of healthy development in all cases (zpi > 2 = 0/12; black points inside dashed black 
line, Figure 1).  The group mean was shifted towards slower reaction times, with eleven of 12 
individuals slower than the control mean (six expected by chance). 
In the analysis of group differences, the model with just an Age2 X Condition interaction was 
essentially equivalent to the best model (∆AIC = 0.2; best model: Condition X Age
2
 + Group X Age
2
),  
which means evidence of a group difference was weak (AIC model selection results are summarised in 
Appendix 2).   
Tyrosinemia III 
 
Individual T3 RT means are displayed in Figure 1b.  They were evenly distributed across the 
control range.  Two individuals had response times that were reliably slower than controls (zpi > 2) 
when performance was averaged across target locations (patient 7 – 8.03 years, patient 9 – 17.64 years). 
The two youngest individuals (patient 1 - 4.40 years, patient 2 - 5.16 years) were on the border (zpi = -
1.92 and zpi = -1.90 respectively).  
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 In group comparisons, the best model included a Condition X Age2 X Group interaction (AIC 
model selection results are summarised in Appendix 3).  The effect of condition was not strong. There 
were, however, strong effects of Age and Group.   A model with just main effects of Age and Group 
was nearly as good as the best model (∆AIC = 1.97) and models without these terms had essentially no 
support (∆AIC=11.12 and ∆AIC=17.19).  The 3-way interaction occurs because T3 individuals are 
slower than the control mean at the earliest ages, closer to the mean in the middle of the age range and 
slow again when they are older, but by much less, and then the differences are somewhat different in the 
different quadrants.  These interaction effects are, however, subtle and the small T3 sample makes them 
potentially unstable.  
In sum, orienting and reacting to an abrupt onset was not slowed in MPS-IVa.  Most individuals 
were slower than the mean, but scores were clustered quite closely in the region of the control mean 
with no individuals outside the control range, so a group difference was not supported.  There was some 
evidence of slowing in T3 and models with a group difference were preferred.  RT slowing was 
concentrated on the youngest and oldest participants.  Since the effect is carried by relatively small 
numbers at the extremes of the age range we should be cautious in our interpretation. Participants 
between 6 and 15 years old were less clearly different.  The lack of differences in MPS-IVa and the 
relatively modest differences isolated to young and old participants for T3 will influence our 
interpretation of other reaction time tasks where differences are more marked, although we must keep in 
mind that speed of processing could be affected in T3. 
Visual Search  
Typically developing Controls (TD) 
Mean reaction time is plotted in the top panels of Figure 2 and search efficiency in the bottom 
panels.  TD controls increased their overall speed with age (top panels) in both conjunction and feature 
search.   The biggest change occurred during the early years, with changes slowing after about 10 years.  
Feature search efficiencies were close to zero at all ages (although there was some decline in 
variability). Accordingly, the best model of feature search included an effect of age but no effect of 
display size. This means the search for a feature difference happened in parallel across all locations in 
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the display no matter how many items there were to search, which is the normal pattern (A. M. 
Treisman & Gelade, 1980).   The best model of conjunction search, in contrast, included an interaction 
between display size and age.  Reaction times always increased when there were more distractors, but 
the time to search each item declined steadily from around 70 to around 32 milliseconds (bottom right 
panel) over the range between 6 and 19 years.  There was also a large drop in variability.  This indicates 
that finding the target in conjunction search requires some degree of item-by-item processing. 
Accuracy supported the same pattern.  Accuracy in feature search increased across ages (from 
94% at age 6 to 98% at age 19).  There was a difference in accuracy on present vs absent trials (90% vs 
98% at age 6) that narrowed with age (99% vs 98% at age 19) and models supported an interaction 
between present/absent and age. There was no effect of display size. The best model of conjunction 
search accuracy included an interaction between display size and target present/absent and an 
interaction between age and present/absent.  The interaction with age was weak because a model with 
just a main effect of age was nearly equivalent (∆AIC = 1.23).  The interaction with display sizes occurs 
because more targets are missed in larger displays.    Accuracy increased with age (85% at age 6 vs 
97% at age 19).  These patterns do not modify the interpretation of the reaction time results (where 
larger displays take longer). 
_________________ 
Figure 2 about here 
__________________ 
Morquio Syndrome (MPS-IVa) 
The biggest difference between individuals with MPS-IVa and controls occurred in the simpler 
task of feature search.  zpi was greater than two in six individuals and between one and two in one other 
individual.  Eleven of 12 individuals were slower than the control mean.  Six would be expected by 
chance.  In conjunction search, zpi was greater than two in three individuals and between one and two in 
four others.  Ten of 12 individuals were slower than the control mean. 
There were no abnormal increases time to search larger displays (i.e. display size effects were 
normal). In feature search, additional items took longer in three individuals (Patient 1, zpi = 2.46; Patient 
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8, zpi = 5.99; patient 11, zpi = 11.25), and, in conjunction search, in two (Patient 8, zpi = 2.57; Patient 11, 
zpi = 3.55).  
Group differences between MPS-IVa individuals and controls were analysed separately for 
feature and conjunction search.  The best model of feature search did not include an effect of Display 
Size and there were no two or three-way interactions. There was a main effect of Age (younger 
participants were slower) and a main effect of age (MPS-IVa individuals were 445ms slower than 
controls).   Models without terms for Group and Age were poor.   
The lack of interaction between Group and Age shows that MPS-IVa individuals make progress 
at a normal rate, neither catching up with controls or falling behind, despite the slower overall times.  
We should be somewhat cautious about this result, however, because there is a small number of 
individuals at each age. 
In the analysis of accuracy, Group was added to the Age by Present/absent interaction from the 
control model.  Instead of the increasing accuracy seen in controls, MPS-IVa individuals initially show 
a bias to "present" and later a bias to "absent" with little consistent change to percent correct.  This is 
not a theoretically important pattern in the present context. Averaging over present/absent conditions, 
the best model included an interaction between Age and Group that resulted from increasing overall 
accuracy in controls, but flat or slightly decreasing accuracy in MPS-IVa individuals.  MPS-IVa 
individuals and controls had equivalent accuracy when averaging across ages (both 94%).  Accuracy 
does not change the interpretation of reaction times.  Accuracy is high in both MPS-IVa individuals and 
controls and there was no indication that longer RTs were associated with higher accuracy in the MPS-
IVa group (R = -0.46, p=.13; a negative R value results when higher accuracy is associated with lower 
RT). 
The top four models of conjunction search were all very similar in their ability to account for 
reaction times (Display size X Age + Group X Age; Display size + Group X Age; Display size X Age + 
Group; Display Size + Age + Group; max change in AIC = 0.8).  Good models all included terms for 
Display Size, Age and Group.   Interactions between Group and Age and between Display Size and Age 
were weak because the simpler model with only main effects was a close equivalent (∆AIC=0.8).   
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It is important to note the lack of interaction between Display Size and Group.  MPS-IVa 
individuals processed each item as quickly as controls, even when efficiencies were above zero and 
each item required additional processing time (~42 ms per item in both MPS-IVa and controls).   The 
Group effect, instead, resulted from a constant amount of slowing at all display sizes (~378 ms for both 
large and small displays). Models without main effects of Display Size, Age or Group were poor.    
In sum, MPS-IVa individuals were clearly slower in visual search.  This difference, however, 
was constant across display sizes.  Item-by-item processing was not slowed.  The upward shift in 
reaction times without display size effects could have at least two origins.  One possibility is that MPS-
IVa individuals occasionally lose concentration or are distracted.  If so, reaction times at the fast end of 
the range should be similar to controls, but there should be more difference in slower reaction times. 
Lapses could be distributed across small and large displays.  A second possibility is that a stage that is 
not sensitive to attentional demands, is affected (a non-decision stage, in the terminology of search 
models). This could be time to initiate search or time to select and program a response. 
To explore these alternatives, we binned reaction times into quintiles for each participant and 
compared quintiles across groups using the vincentizing method (Ratcliff, 1979; see Romani, 
MacDonald, De Felice, & Palermo, 2017 for this kind of analysis in a population of individuals with 
PKU).  Figure 3 shows reaction times and standardised differences between means for individuals with 
MPS-IVa and controls in each quintile.  To standardise, we divided the difference between MPS-IVa 
and control means by the standard error of the control mean.  Because reaction time distributions have 
an extended tail associated with the longest reaction times, the variance in the final bin is higher than  
the other bins, and interpretation of quintile differences needs to take this increased variance into 
account.   We will concentrate on two aspects of the difference curves.  We will ask, first, if MPS-IVa 
quintile means are slower than controls (difference scores > 0). We will also ask if differences are 
increase across quintiles, particularly quintiles 2, 3 and 4, showing increasing differences with longer 
reaction times.   
_________________ 
Figure 3 about here 
_________________ 
Page 18 of 54
URL: http://mc.manuscriptcentral.com/pcgn
Cognitive Neuropsychology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
Cognitive function in Morquio and Tyrosinemia  Page 19  
 
 With one exception, there were relatively stable differences across the full range of quintiles in 
MPS-IVa, not increasing differences.  In feature search at ages 5-8, conjunction search at ages 8-10.5 
and both feature and conjunction search at ages 10.5-14 reaction times were always slower, even in the 
fastest bins (t>2.3; p<.03) but differences did not increase.  Feature search at ages 8-10.5 was the only 
condition with increasing differences (conjunction search at ages 5-8 showed no differences, all t< 1.8, 
all p>0.08), The overall pattern does not support distraction/failures of attentional control or the 
accumulating effects of general slowing.  Instead, initiation or response processes are possible loci. 
Tyrosinemia III (T3) 
In feature search, four of eleven T3 individuals had zpi  > 2 for mean RT. An additional two had 
zpi between 1 and 2 (Figure 4).  In conjunction search, five of eleven individuals had zpi  > 2 and two had 
zpi between 1 and 2.  Only one individual had a search efficiency zpi  greater than two and three had zpi 
between 1 and 2. 
______________ 
Figure 4 about here 
______________ 
Group differences were analysed separately for feature and conjunction search.  The best model 
for feature search included an Age by Group interaction.   There were more individuals further from 
controls at older ages.  There was a ~76 ms difference between groups when participants were under 12 
years old, with as many T3 individuals below the control mean as above it.  Individuals older than 15 
years were, on average, ~187 ms slower than controls, and all four T3 individuals were above the mean.  
There was no effect of Display Size, indicating that feature search was efficient for both groups. 
The best model for accuracy in feature search included an interaction between Present/absent, 
Age and Group, adding Group to the interaction from the control model.  As with MPS-IVa, there was a 
different pattern of Present/absent effects compared to controls.  Accuracy was relatively constant, but 
Present trials showed some decrease.  Overall, T3 individuals were less accurate than controls (89% vs 
93%).  There was no evidence of a speed/accuracy trade-off that would modify interpretation of the 
reaction time results. 
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In conjunction search, the best model of reaction times included main effects of Display Size, 
Group and Age, but no interactions to suggest group differences in display size or age effects.   The 
group difference was an average of 71 msec when participants were below 12 years old and 133 ms 
when participants were above 15 years old.   
Models of accuracy in conjunction search included a Group by Display Size by Age by 
Present/absent interaction. The present/absent variations are unlikely to be theoretically important.  
When present/absent conditions were collapsed and individuals put in two age groups to increase N 
(less than or greater than 12 years old), models required a Group by Display size by Age interaction.  
Accuracy was lower than controls (80% vs 90%) and the display size effect was larger in younger 
individuals only (accuracy dropped by 12% when young individuals viewed larger displays, but only by 
1-3% in older T3 individuals, young controls and old controls).  
 We examined the source of slower RTs using the quintile method described above.  In contrast 
to MPS-IVa,  T3/control differences increased across quintiles (Figure 5).  At ages 4.5-6, differences in 
both search tasks increased in bins 1-3 and then levelled out.  At ages 6-8.5 there were no differences 
from controls.  At ages 15-19, differences increased across all bins in both search tasks.  In the youngest 
and oldest T3 individuals, reaction times were different even in the first bin (all t>2.3; p<.03), showing 
that T3 individuals in these groups were always slower, but the differences increased for longer reaction 
times.  Different patterns at different ages should be interpreted with caution because the number of 
individuals at each age is small. 
_____________ 
Figure 5 about here 
_____________ 
In sum differences in visual search were sometimes observed more in accuracy and sometimes 
more in reaction times, but there was a relatively consistent difference. At the level of individuals there 
was considerable variability.  Seven of 11 individuals recorded reaction times that were slower than the 
control mean in feature search and seven of 11 in conjunction search (not always the same individuals).  
This was not a marked difference because the value expected by chance is 5.5 (recall that in MPS-IVa 
nearly all individuals were above the control mean).  There was some indication that performance got 
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worse with age.  This was, however, based on small numbers, so we should be cautious about how 
strongly we interpret the effect.  RT quintiles showed increasing differences for longer reaction times.  
This was not consistent with increased processing for more difficult displays because 1) the pattern was 
the same in both feature and conjunction search (difficulty does not increase with display size in feature 
search) and 2) conjunction search efficiencies (which measure increasing difficulty) were normal.  It is 
possible that occasional long reaction times were based on distraction, but this would not account for 
the differences in the first quintiles.  There may also be slowing which affects all quintiles, as in MPS-
IVa, during initiation or response stages.  We will return to the issue of distraction when we discuss the 
fixation task. 
Language  
Typically developing Controls (TD) 
Control participants showed imp ovement with age in both the BPVS (∆AIC = 163) and the 
BNT (∆AIC = 58; Figure 6). 
________________ 
Figure 6 about here 
________________ 
Morquio Syndrome (MPS-IVa) 
Patient 12 did not complete the Boston Naming Test (BNT) because of time constraints.  BPVS 
and BNT scores are shown in Figure 6a. On the Boston Naming Test, one individual scored below the 
control mean (patient 6; zpi = -3.17) and one scored above (patient 7; zpi = 2.74). Three other individuals 
had zpi between -1 and -2. The best model for the Boston Naming Test included only a term for changes 
with age.  There was no evidence that MPS-IVa individuals performed worse than controls. 
No BPVS scores were  further than two standard deviations below the mean, but 7/12 
individuals were between one and two standard deviations below (Figure 7).  The best model for BPVS 
scores included an interaction between Group and Age, but evidence for the interaction was weak 
because the model without the interaction was nearly equivalent (∆AIC = 0.7).  
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In sum, MPS-IVa individuals showed no difference from controls in productive vocabulary and 
only minor differences in receptive vocabulary with no individuals or very few outside the control 
range. 
Tyrosinemia III (T3) 
Just over half of the T3 individuals were more than two standard deviations below the mean on 
the BNT (6/10 individuals).   The best model for BNT results included an interaction between Age and 
Group.  The difference between T3 individuals and controls widened with age (Figure 6b).  The 
difference at the earliest ages was 18, but widened to 56 in the oldest individuals.   
On the BPVS, the majority of T3 individuals were more than two standard deviations below the 
mean (8/11 individuals).  The best model included an interaction between Age and Group.  Once again, 
the difference between T3 individuals and TD controls got larger with age (Figure 8).  At the earliest 
ages (6 years) the estimated difference was 32 points.  By 19, the estimated difference had grown to 63 
points.  Models without terms for either Age or Group were poor. 
Unlike MPS-IVa, where the differences from controls were small, T3 individuals show clear 
problems with language tasks that become more marked with age. 
Oculomotor Tasks 
Oculomotor tests included a fixation task and a saccade task.  Morquio patients 5 and 7 did not 
want to attempt the saccade task and patients 2, 3, 4 and 11 did not complete all saccade trials due to 
fatigue. T3 patient 2 was unable to complete the oculomotor tasks due to postural difficulties which 
prevented eye tracking. 
Fixation task – Dwell time 
Typically Developing Controls 
Dwell time is the total time spent fixating the target during a trial (summing initial fixation and 
re-fixation times).  Dwell time in controls was described by a quadratic model with an interaction 
between Condition and Age2 (Figure 7).  Systematic modelling `revealed some advantage for top 
targets, but this was subtle.   
__________________ 
Figure 7 about here 
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__________________ 
Morquio Syndrome (MPS-IVa) 
The majority of MPS-IVs individuals exhibited fixation dwell time deficits (Figure 7a; zpi < - 2 
in 8/11 individuals). The best model of MPS-IVa and control data included all 2-way interactions.   The 
Group X Condition interaction reflected differences between quadrants that were larger for MPS-IVa 
individuals than controls (control maximum difference, top vs bottom = 160 msec; MPS-IVa  maximum 
difference, top vs bottom, 906 msec).  The Group X Age2 interaction reflected larger differences 
between groups at younger ages.  The model without this interaction was nearly equivalent, however, so 
the difference was weak (∆AIC=2.1).  The strongest difference was that MPS-IVa individuals fixated  
the target for considerably less time than controls (difference = -1083 msec), and a model without the 
Group term was poor (Condition X Age
2 
model, ∆AIC = 55). 
Tyrosinemia Type III (T3) 
 Results are presented in Figure 7b. As a group, T3 dwell times were shifted below the control 
mean (Average zpi < 0 in 8/10 individuals), with four individuals who were different enough to be 
completely outside the control range.   The best model of T3 and control data included interactions for  
Condition X Age2 and Condition X Group.   The Condition X Group interaction reflected differences 
between quadrants that were larger in T3 individuals (maximum difference of 158 msec in controls 
compared to 528 msec in T3).  There was a group difference (model without Group, ∆AIC = 17), but it 
was smaller and carried by fewer individuals than in MPS-IV.   
Fixation Task – Intrusive Saccades 
Typically Developing Controls 
The number of intrusive saccades, where fixation moved away from the target during the period 
when participants were supposed maintain fixation, was defined by a quadratic function (Figure 7). 
where the majority of age-related change occurred before 10 years. A model which included a 
Condition X Age2 interaction was clearly better than a model that did not (∆AIC = 8).  There were some 
minor differences due to location (fewer intrusive saccades for top targets) but these were subtle. 
Morquio syndrome (MPS-IVa) 
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Seven MPS-IVa individuals made more intrusive saccades than controls (7/11 zpi > 2; Figure 
7a).  These seven also had shorter dwell times.  Dwell time would be expected to be shorter when there 
are frequent intrusive saccades. One individual, however, was within the control range for intrusive 
saccades but not dwell time (patient 7).  They held their first fixation on the target for a shorter time but 
did not go back and forth between the target and other locations.   Examples of saccade and fixation 
deficits in two individuals are shown in Figure 8. 
________________ 
Figure 8 about here 
________________ 
The best model of group differences included a main effect of Group and an interaction 
between Age
2 
and Condition, showing that intrusive saccade suppression was poorer in MPS-IVa 
compared to controls.  
Tyrosinemia III (T3) 
 Unlike MPS-IVa, intrusive saccade frequencies were normal in the majority of T3 
individuals (Figure 7b; 8/10 zpi  < 2). Two older individuals (patient 9 and 11) had more substantial 
problems across target locations. Importantly, patient 9 also exhibited fixation time deficits, and it is 
clear from the eye movement traces that fixation on the target was disrupted by intrusive saccades 
towards the screen centre.  Group differences were best explained a model with Group X Age2 and 
Condition X Age2 interactions, but a model with without an effect of Group was essentially equivalent 
(∆AIC = .05). 
   
Pro-saccade Task – Saccade Onset time 
Typically Developing Controls 
Figure 9 plots saccade onset times for TD controls.  Saccade onset time decreased with age and 
the majority of change occurred between 5 and 12 years. The data were log transformed because 
residuals increased at higher values.  There was a clear preference for a model that included an Age
 
X 
Condition interaction. A model with separate trajectories for top and bottom targets, and a shared 
trajectory for horizontal targets was best. The location that took longest to react to at 6 years old was the 
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bottom target (max bottom, 307 ms vs min right, 247 ms).  At older ages the differences narrow and the 
order changes (max top, 186 ms vs min right, 161 ms at 19 years). 
________________ 
Figure 9 about here 
________________ 
MPS-IVa (Morquio syndrome) 
Individual MPS-IVa saccade onset values are shown in Figure 9a.  All MPS-IVa individuals 
were within the control range. The best model included an interaction between Group and Condition 
and Age and Condition. Group differences varied some by target location, but there was not an 
interpretable pattern and there was no evidence of a main effect of group independent of the interaction 
with condition (The model with just an Age X Condition interaction was better than the model that 
included an Age X Condition interaction and a main effect of Group, ∆AIC = 1.39; means collapsing 
across location differed by less than 1 msec). 
Tyrosinemia type III 
Individual T3 saccade onset values are shown in Figure 9bf.  Averaged across target locations, 
only one individual (patient 9, 17.98 years) had a zpi > 2.  This individual also had fixation time and 
intrusive saccade deficits.  Models of saccade onset did not support a group difference. 
In sum, neither metabolic disease group was systematically slower to initiate saccades. 
Pro-saccade Task – Saccade Peak Velocity 
There was no evidence of differences in saccade velocity when either disease group was 
compared to controls. The preferred model for MPS-IVa did not include a term for Group.  The T3 
model without a Group term was essentially equivalent to the best model (∆AIC=0.6).   
 
Discussion 
We examined cognitive functioning in two rare inherited metabolic diseases – Morquio 
syndrome (MPS-IVa) and tyrosinemia type III. We compared individuals with metabolic disease to 
controls using formal tools for model selection and a developmental trajectory approach. This provided 
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a richer way of evaluating developmental differences than traditional age-matched comparisons.  We 
were able to separate different types of developmental effects, including changes to the rate of 
development and constant decrements in performance in the presence of a normal rate of development.  
We included both analysis of group performance and individual comparisons (based on prediction 
intervals).  These contributed different, but complementary information. 
In both diseases we found cognitive effects, but with different functional profiles, showing that 
metabolic disease creates specific cognitive effects, and does not just produce homogenous and general 
decrements in performance.  Sustained attention was affected in MPS-IVa and language, especially, but 
also sustained attention in T3.   These are potential candidates for sensitive markers of disease 
progression and they document selective functional impacts that can be considered alongside 
descriptions of biological changes. A summary of effects across cognitive domains is shown in Table 1. 
MPS-IVa (Morquio Syndrome) 
Few studies have investigated cognitive performance in MPS-IVa (Morquio syndrome), 
primarily because clinical observations report normal intellectual function (Dvorak-Ewell et al., 2010; 
Wraith, 2006).  A recent study, however, reported mild cognitive changes (Davison et al., 2013) and 
highlighted difficulties with attention.   We did more detailed cognitive testing and we also found 
attention deficits in several tasks.   Fixation dwell time was lower and disrupted by intrusive saccades.  
MPS-IVa individuals had difficulty sustaining attention after the natural engagement created by an 
abrupt visual onset had ended. Visual search times were slower, but without a decrease in search 
efficiency.  Item-by-item processing was normal.   Analysis of the reaction time distributions showed 
that both fast and slow search times were delayed and differences did not increase for slower reaction 
times.   This was not consistent with occasional lapses of attention, which should introduce larger 
differences for slower reaction times.  There was no evidence of general slowing since simple reaction 
time, saccade onset times and saccade velocities normal or only weakly affected and differences did not 
increase with difficulty (slower RTs were not more delayed and search efficiencies were normal).     
Instead, search results point to delays in a stage that is unrelated to attentional demands, like task 
preparation or response decision, which would slow both fast and slow responses.  We did not find a 
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natural connection that links results from the fixation task and visual search. Each task suggested a 
different deficit.  If there was a connection between them this is not currently clear. 
An offset in search times, with slower times overall, but not slower item-by-item processing 
(i.e. unchanged effects of display size) has been reported under several conditions in the literature, most 
importantly, under a working memory load and in aging.  When a non-spatial working memory task 
must be completed at the same time as visual search, search slows but search efficiency is unchanged 
(Oh & Kim, 2004; Woodman, Vogel, & Luck, 2001).   Older adults also show slower search times, 
without increased display-size effects (Gorman & Fisher, 1998; Monge et al., 2017; see also Ratcliff, 
Thapar, & McKoon, 2006 for a similar increment in a discrimination task that is attributed to “non-
decision” aspects of the task).  Reduced capacity could be a factor in common between aging and dual 
tasking and may also explain our results, but note that this cannot be the same as general slowing since 
in MPS-IVa both simple RT and saccade onset times were either unaffected (saccade onset time) or 
only weakly affected (simple RT).   
The fixation task may index the difficulties with sustained attention reported by parents in the 
Davison et al. (2013) study.  Difficulties concentrating could be the everyday consequence of the same 
problem that reduces fixation times during formal testing.   Indeed, maintaining fixation involves 
mechanisms that are not isolated within the system for eye-movement control.  The areas that are 
responsible for maintaining fixation (Krauzlis, Goffart, & Hafed, 2017), including areas in dorso-lateral 
prefrontal cortex, the frontal eye fields and the superior colliculus, are areas that have connections to 
other modalities:  auditory or proprioceptive, in the case of the frontal eye fields (Medendorp, 
Buchholz, Van Der Werf, & Leoné, 2011); or movement control, in the case of the superior colliculus 
(Krauzlis et al., 2017).  The frontal eye fields, for example, are thought to “encode ‘supramodal’ 
representations to guide attention and behaviour” (Medendorp et al., 2011).  Problems in these areas 
could plausibly the source of general attentional issues. 
In sum, our results highlight difficulties in MPS-IVa with sustained attention and with task 
preparation or response decisions.  They extend the preliminary results reported by Davison et al. 
(2012) and they show that the differences in attentional tasks occur without commensurate changes in 
other cognitive tasks (e.g. language tasks; item-by-item processing in selective attention) or general 
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slowing (as reflected in normal or near normal simple reaction time, saccade onset and saccade 
velocity). 
Tyrosinemia III (T3) 
In Tyrosinemia III, there were clear deficits in both language production (BNT) and 
comprehension (BPVS) and differences from controls appeared to widen with age.  
There were also differences in average search times, simple RT and dwell time.  Item-by-item 
processing in visual search was not affected (the same pattern as MPS-IVa), but the differences between 
T3 and controls were more marked for longer reaction times, consistent with occasional attentional 
failures (different from MPS-IVa).  Dwell times in the fixation task also pointed to problems sustaining 
attention.  There was some evidence of slowing in simple RT.  Slowing, like lapses in attention, predicts 
differences that increase with difficulty, consistent with the conjunction search results.  Slowing, 
however, does not provide a good account other aspects of the pattern because: 1) Display size effects 
in conjunction search were normal and slowing predicts larger differences for more difficult conditions; 
2) Simple feature search produced the same pattern as conjunction search--increasing differences with 
slower RTs--but larger displays are not more difficult in feature search, showing that slowing occurs 
even when there is no change in difficulty; 3) There was no evidence of slowing in saccade onsets or 
saccade velocity.  Search RT differences were larger for slower RTs, but even the fastest T3 search RTs 
were slower than controls.  This means that lapses in attention do not explain the whole T3 pattern and, 
like MPS-IVa, there must be problems that are unrelated to attentional demands. 
To our knowledge, this study represents the most detailed cognitive assessment of T3 to date 
and highlights, especially, language impairments, but also problems with sustained attentional and age-
related decline. Our results provide formal tests to confirm and extend the case-based findings of 
Ellaway et al. (2001), who described mild to moderate intellectual impairments in a sample of 12 
individuals, but without specific information about cognitive testing.   
The prevalence of language deficits is a frequently-reported cognitive feature of T1 individuals 
treated with  NTBC (Bendadi et al., 2014; Thimm et al., 2011).  Since NTBC treatment blocks the 
biochemical pathway at the same place it is blocked in T3, treated T1 resembles T3, except that T1 
individuals are subject to both high levels of tyrosine and potential collateral effects of NTBC.   
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Our results suggest that the cognitive impairments in T1 are related to the high levels of 
tyrosine rather than NTBC.  Several lines of evidence converge on this. Our T3 individuals have raised 
tyrosine but no NTBC and they have similar impairments to treated T1 individuals.  Learning 
impairments are present in the mouse model of T1 after NTBC treatment, but not in healthy mice who 
are given NTBC, suggesting that raised tryosine is the source of impairment,  not NTBC (Hillgartner et 
al., 2016).  Finally, Ellaway et al. (2001) reported that T3 individuals who were put on a low tyrosine 
diet later had more severe symptoms than individuals who began a diet earlier and Ellaway et al. 
speculated that elevated tyrosine levels in cerebrospinal fluid (CSF) were particularly damaging during 
infancy.  We did not analyze biochemical data, but some of the variance in the cognitive performance in 
our sample could result from individual differences in tyrosine levels that, in turn, could be based on 
variations in early exposure or dietary compliance. Relating tyrosine concentrations at different ages to 
cognitive performance will be an important step toward understanding how and when tyrosine affects 
the brain and when dietary control is critical for effective treatment. 
The behavioural consequences for T1 mice treated with NTBC are worth noting in relationship 
to the language deficits we found.  Hillgartner et al (2016) found that NTBC treated T1 mice were 
slower to learn in a maze task.  Both the BNT and the BPVS are tests of vocabulary.  That is, they test 
the facility with which words are processed or stored in the mental dictionary.  Both tests would be 
sensitive to problems with word learning.  It could be word learning, rather than a deficit affecting 
phonological or lexical representations directly, that is the source of differences in our T3 individuals.  
The cognitive neuropsychology of metabolic disease  
Our results show that neurodegeneration from metabolic disease is not a uniform process.  
We did not find homogeneous declines across diseases and tasks.  Patterns from were different.  There 
was a diversity of preserved and impaired capacities across language, sustained attention, selective 
attention and processing speed even if the precise underlying mechanisms are difficult to pinpoint at 
this stage.  Since the different metabolic diseases affect different chemical systems in the brain, this 
shows that neuro-cognitive systems are not just differentiated by anatomical location.  Brain networks 
critical for different cognitive functions are differentially sensitive to specific cellular support systems.  
We can begin to ask “why?”  Are there systems, for example, that are particularly sensitive to neural 
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transmission speed, network synchronization, specific neurotransmitters, growth or membrane 
changes—all properties that would be directly influenced by the biochemical environment?   What is 
the functional aspect of the system that makes these characteristics critical?  This is a relatively 
unexplored dimension, within neuropsychology, that is orthogonal to the understanding of anatomical 
loci and networks.  These questions will be critical, however, to understanding the brain as an integrated 
biochemical and anatomical system and they will be critical to our understanding of disease. 
For MPS-IVa, what we can say about the relationship between metabolic processes and 
cognition is limited because it has typically been described as a condition that doesn’t have cognitive 
impacts.  As a result, there has been little effort to explain how a deficiency in N-acetylgalactosamine-6-
sulfatase (GALNS) might affect the brain.  Davison et al. (2013) were probably the first to offer some 
possibilities.  GALNS breaks down karatan sulfate and chondroitin-6-sufate, and these substances help 
coordinate neuroaxonal connection formation (Miller, Sheppard, & Pearlman, 1997).  In addition, MPS 
IVa may affect calcium signalling, and connections between calcium signalling, mitochondria and 
neurodegeneration have been made for Huntington’s disease, amyotrophic lateral sclerosis, Alzheimer’s 
disease and Parkinson’s disease (Marambaud, Dreses-Werringloer, & Vingtdeux, 2009).  Finally, 
calcium signalling plays an important role in long term potentiation and excitotoxicity, two additional 
routes to cognitive effects (Marambaud et al., 2009). 
Tyrosinemia type III, allows more specific hypotheses.  As we have noted, T3 involves a 
defect in the enzyme which is needed to break down tyrosine, and tyrosine is a precursor of both 
dopamine and norepinephrine.  This creates several avenues for cognitive effects, as outlined by 
Hillgartner et al. (2016) in their discussion of NTBC-treated T1:  1) increased tyrosine; 2) increased 
dopamine (produced by conversion from tyrosine); 3) decreased large amino acids (because they are 
outcompeted by tyrosine, including tryptophan, the precursor of serotonin); or 4) decreased serotonin 
(due to lack of precursor).    Hillgartner et al., however, go on to hypothesize that cognitive problems in 
NTBC-treated T1 are unrelated to any of these primary effects, and are caused, instead, by two by-
products of defective tyrosine break-down:  one that is neurotoxic (succinylacetone) and the other that 
is both neurotoxic and causes demyelination (δ-ALA).  This is possible if, as Hillgartner et al. speculate, 
NTBC is poorly transported into the brain, and tyrosine catabolism in the brain proceeds past the point 
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where NTBC treatment stops it in the rest of the body.   The problem with this hypothesis is that it 
cannot explain cognitive effects in T3.   The enzyme that is defective in T3 acts at the same point that 
NTBC acts, but it will be defective in all cells, including those in the brain.  The toxic by-products that 
Hillgartner et al., identify are not produced in T3, but our results show that there is still cognitive 
impairment, pointing to some combination of the primary biochemical effects as the cause. 
 Cognitive neuropsychology of development 
 The study of cognitive development in populations with inherited metabolic disease 
presents both challenges and opportunities (see also, for example, Pitchford & Funnell, 1999).  
Development involves changes over time and also potential dependencies among changing capacities.  
Theories of development must specify the time course of intrinsic or environmentally conditioned 
change, the environmental inputs that are required for development, and potential dependencies among 
capacities.   The pattern of dependencies that support successful development is not guaranteed to 
persist when the system is mature, which means that development cannot be transparently inferred from 
either the mature system or insults to that system.   
The complexity of the relationship between adult and developmental models can be illustrated, in 
terms that will be familiar to readers of Cognitive Neuropsychology, in the domain of reading.  It is 
relatively clear, from cognitive neuropsychological results, that sub-lexical and lexical mechanisms for 
reading are largely independent components in the mature system and all major reading models include 
them (Coltheart, Rastle, Perry, Langdon, & Ziegler, 2001; Harm & Seidenberg, 1999; Zorzi, 2010).   
The relative independence of these systems in adulthood, however, does not mean that they are 
independent during learning.  This is apparent from developmental dyslexia (e.g. Hulme & Snowling, 
2016) or more directly, in the context of the current discussion, from acquired dyslexia after a stroke in 
childhood (Pitchford & Funnell, 1999).   As they have in other areas of neuropsychology, the 
consequences of brain damage can reveal properties of components and dependencies in a 
developmental (rather than a static) model that are not available in other ways.  Although there are 
many studies of developmental cognitive difficulties, the approach that involves characterising 
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components and dependencies in a detailed developmental cognitive model, of the sort that readers of 
Cognitive Neuropsychology would find familiar, is relatively underdeveloped.3 
Our results are too preliminary to show this promise except in outline, but they do show that 
developmental effects from metabolic disease can be selective enough to allow tests of functional 
models and they illustrate both some methodological issues and some approaches that offer solutions. 
One of the basic problems is that development is a moving target.  The statistical models of 
developmental trajectories that we have introduced here provide some solutions.  They allowed us to 
compare individuals in disease groups and controls across a range of ages when performance is 
changing and to separate offsets, which create differences across all ages, from changes to 
developmental rates.   Age did not substantially modify the group differences in visual search or 
fixation tasks for MPS-IVa.  There were differences at all ages.  Age, instead, did modify T3 language 
results, where there appeared to be age-related decline. 
Capturing developmental trajectories becomes an even more powerful tool when longitudinal data 
are available.  Trajectories from individuals with disease can be compared to control trajectories.  
Variance in rates of development will show whether there is, for example, consistent decline, or 
heterogeneity in the impact of disease over time.  If individuals need to be tracked clinically, 
longitudinal trajectories could identify individuals who are not following the normal course of 
development before their performance is different from controls at any single point in time, providing a 
more sensitive test of disease progression. 
The issue of sensitivity and the contrast between what is apparent in individual data and group data 
is already clear with our samples.  Effects in some individuals that do not occur in all individuals in the 
group are common.  Data from a group, however, can also show that there are deficits even when the 
individual data do not.   Conjunction search results for MPS-IVa were a case in point.  Only 3 
individuals were outside the control range, but the population, as a whole, was clearly shifted toward 
slower RTs, with only two individuals faster than the control mean.  There is a very low probability that 
                                                     
3This is not to deny that lexical and sub-lexical mechanisms can display dissociations also during 
development (see summary in Castles, Bates, & Coltheart, 2006),  but these dissociations do not exclude the 
possibility that there are also learning dependencies between components that could be revealed by developmental 
studies in a way that is not possible in adults (as Castles, Bates & Coltheart, 2006, note, p. 881, and as the methods 
of Pitchford & Funnel, 1999, illustrate). 
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so many scores would be slower the control mean in an unimpaired sample.  This is clinically important 
because it highlights the limits of individual samples for some questions (i.e. is there impairment from 
disease in this group or not?) and also reinforces the point that techniques like longitudinal sampling 
may be needed to detect decline at the earliest possible moment in individuals. 
The statistical approach we have adopted is a powerful method to deal with developmental data and 
with relatively small samples.    There are, however, limits that small samples, which are inevitable in 
rare diseases, impose.  We cannot, for example, say very much about whether a group trajectory derived 
from cross-sectional data is a good representation of how diseases progress in individuals, and we have 
avoided fitting a trajectory to the disease groups.  In a small sample, especially with relatively high 
variability, the precise shape, inclination or location of the trajectory can be highly unstable and shows, 
again, the need for longitudinal data.  When the changes over time are clearer, as in the T3 language 
data, the statistical models give stronger support to the interaction between group and age.  Even when 
this is the case, however, the precise location or shape of the trajectory may be relatively uncertain. 
Conclusion 
Our study introduces new data and methods that illustrate the promise of cognitive assessment for 
inherited metabolic diseases. Two cohorts showed that specific measures were sensitive in each disease 
(e.g. sustained attention in MPS-IVa or language in T3) and could be developed further into new tools 
to help track disease progression or quantify treatment benefits. In addition, we have shown how 
cognitive assessment can help to reveal the biochemical basis of cognitive effects. Finally, our results 
make several extensions possible.  Cognitive performance can be related to changes in structure, 
activity or biochemistry as measured by MRI, fMRI, MRS or EEG to triangulate the biological basis of 
cognitive changes.  Our analysis of different aspects of performance show, however, that a detailed 
functional description of cognitive processes will remain a central component of this project.  Extending 
the methods described here to longitudinal data is a promising next step for understanding the cognitive 
impacts of inherited metabolic diseases.  
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Table 1: Summary of cognitive deficits across cognitive domains. 
Task
Number of patients 
with scores worse 
than control mean
Number of 
patients with 
zpi  > 1
Number of 
patients with 
zpi  > 2
Evidence of 
control/ 
patient 
difference?
Number of patients 
with scores worse 
than control mean
Number of 
patients with 
zpi  > 1
Number of 
patients with 
zpi  > 2
Evidence of 
control/ 
patient 
difference?
11/12 3/12 0/12 weak 7/11 4/11 3/11 yes
Visual search
Overall search 
time 11/12 7/12 6/12 yes 7/11 6/11 4/11
older 
patients
7/12 5/12 3/12 no 1/11 1/11 0/11 no
no yes
Overall search 
time 10/12 7/12 3/12 yes 7/11 7/11 5/11 yes
6/12 2/12 2/12 no 4/11 3/11 1/11 no
no yes
Language
7/11 4/11 1/11 no 9/10 8/10 6/10 yes
BPVS 9/11 7/11 0/11 weak 11/11 10/11 7/11 yes
Oculomotor tasks
Fixation task
Dwell time 11/11 10/11 8/11 yes 9/10 6/10 2/10 yes
Intrusive saccades 9/11 7/11 5/11 yes 3/11 2/11 1/11 no
Prosaccade task
Onset time 5/9 1/9 0/9 no 5/9 2/9 1/9 no
Saccade velocity 6/9 1/9 0/9 no 1/9 0/9 0/9 no
Tyrosenimia III
Feature search
Simple reaction time
Conjunction search
Increasing differences 
across quintiles?
Increasing differences 
across quintiles?
Effect of display size
Effect of display size
Boston Naming Test
MPS-IVa
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A) MPS-IVa         B) Tyrosinemia III 
  
 
Figure 1. Mean simple reaction time for (A) MPS-IVa and (B) Tyrosinemia III individuals (filled circles) and typically developing controls (open circles). The developmental 
trajectory for controls is plotted as a solid line with 95% prediction intervals (dashed lines).  Reaction times are collapsed across target locations. 
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Figure 2. Overall mean RT and search efficiencies (display size slopes) in a visual search task for MPS-IVa individuals (filled circles) and controls (open circles).   Feature search 
results are in the left panels and conjunction search on the right.  The developmental trajectory for controls are is plotted as a solid line with 95% prediction intervals (dashed lines). 
The red dotted line in the efficiency plots represents efficient search (no increase in reaction time for larger displays).  
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Figure 3. MPS-IVa and Control reaction times from feature and conjunction search.  Reaction times are displayed in quintile bins along with the difference between quintile means for 
patients and controls (control value = 0).  Differences between means were standardised by the standard error from the control bin.   Note change in scale for final two difference 
plots.  
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Figure 4.  Overall mean RT and search efficiencies (display size slopes) in a visual search task for T3 individuals (filled circles) and controls (open circles).   Feature search results are 
in the left panels and conjunction search on the right.  The developmental trajectory for controls are is plotted as a solid line with 95% prediction intervals (dashed lines). The red 
dotted line in the efficiency plots represents efficient search (no increase in reaction time for larger displays).  
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Figure 5. Tyrosinemia III and Control reaction times from feature and conjunction search.  Reaction times are displayed in quintile bins along with the difference between quintile 
means for patients and controls (control value = 0).  Differences between means were standardised by the standard error from the control bin.  Note change in scale for final two 
difference plots. 
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A) MPS-IVa 
   BNT        BPVS 
 
    
    B) Tyrosinemia III 
   BNT            BPVS 
 
   
Figure 6. Boston Naming Test (BNT; production) and British Picture Vocabulary Scale (BPVS; comprehension) scores for (A) MPS-IVa and (B) Tyrosinemia III individuals and 
controls. Patients are filled circles and typically-developing controls are open circles.  Typically developing trajectories (solid line) and 95% prediction intervals are included (dashed 
lines).  
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A) MPS-IVa 
   Dwell time        Intrusive saccade count 
 
     
 
B) Tyrosinemia III 
   Dwell time        Intrusive saccade count 
 
   
Figure 7. Fixation dwell time and intrusive saccade counts for (A) MPS-IVa and (B) Tyrosinemia III individuals (filled circles) and TD controls (open circles). Typically developing 
trajectories (solid line) and 95% prediction intervals (dotted lines) are included. Measures are collapsed across target locations. 
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Figure 8.  Example eye-movement records showing fixation time and intrusive saccades for MPS-IVa patients 7 and 11. The 
visual stimulus (blue line) is presented along with eye position of the patients (black line) and age-matched TD controls (red 
dashed line). Both patients showed fixation duration deficits buts only patient 11 displayed an elevated intrusive saccade 
count. Patient 7 disengages before the end of the trial. 
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A) MPS-IVa                B) Tyrosinemia III 
    
Figure 9. Average saccadic onset time for (A) MPS-IVa and (B) tyrosinemia III individuals (black dots) and TD controls (outlined grey dots). Typically developing trajectories (solid 
line) and 95% prediction intervals (dotted lines) are included. Onset times are collapsed across target locations. 
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Appendices 
Appendix 1.  MPS-IVa and Tyrosinemia III patient demographics 
 
Group PID Gender CA (Years) BPVS MA 
(Years) 
Linguistic Profile 
MPS-Iva 1 M 5.27 4.02 BL – English / Pashto 
MPS-Iva 2 F 6.44 5.00 BL – English / Pashto 
MPS-IVa 3 F 6.48 5.07 BL – Pashto / English 
MPS-IVa 4 M 7.77 8.02 BL – English / Pashto 
MPS-IVa 5 F 9.33 8.07 BL – Pashto / English 
MPS-IVa 6 F 9.79 10.08 ML – English 
MPS-IVa 7 M 9.84 7.07 BL – Manderin / English 
MPS-IVa 8 M 10.28 7.06 BL – Pashto / English 
MPS-IVa 9 M 11.71 15.10 ML - English 
MPS-IVa 10 M 11.78 7.10 ML - English 
MPS-IVa 11 F 12.05 11.04 BL – English / Pashto  
MPS-IVa 12 M 14.39 11.03 BL – English / Pashto 
      
T3 1 F 4.42 5.32 BL – English / Pashto 
T3 2 M 5.23 3.08 BL – Pashto / English 
T3 3 F 6.28 5.32 BL – English / Punjabi 
T3 4 M 6.62 9 ML - English 
T3 5 F 7.48 5.92 BL – English / Pashto 
T3 6 F 7.83 5.00 BL – Pashto / English 
T3 7 M 8.25 2.92 BL – English / Pashto 
T3 8 M 15.81 5.32 BL – English / Pashto 
T3 9 M 17.68 7.92 BL – Pashto / English 
T3 10 F 19.52 6.08 BL – English / Punjabi 
T3 11 F 19.81 10.32 BL – English / Punjabi 
Note: ML, Monolingual, BL, Bilingual 
 
  
Page 50 of 54
URL: http://mc.manuscriptcentral.com/pcgn
Cognitive Neuropsychology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
Appendix 2.  MPS-IVa model results. 
Model 
AIC ΔAIC 
Akaike 
Weight 
     
 
Simple RT 
  
  
Generating model: Condition X Age2 X Group 
  
  
Random effects structure:  (1|Participant) + (1|Age) 
  
Condition X Age
2
 + Age
2
 X Group -458.7 0.0 0.23 
Condition X Age2 + Group -458.7 0.0 0.22 
 
Condition X Age2 -458.5 0.2 0.20 
 
Condition X Age2 + Age2 X Group + Condition X Group -455.8 2.8 0.05 
Condition X Age2 + Condition X Group -455.8 2.9 0.05 
Age
2
 X Group -455.4 3.3 0.04 
 
Feature search 
  
  
Generating model: Display Size X Age X Group 
  Random effects structure:  (1+Display Size|Participant) 
      Age + Group 3182.2 0.0 0.24 
 
Display Size + Age + Group 3182.5 0.3 0.20 
 
Group X Age 3183.6 1.4 0.12 
  
Display Size X Age + Group 3183.7 1.5 0.11 
  
Age X Group + Display Size 3183.9 1.7 0.10 
 
Display Size X Group + Age 3184.5 2.3 0.07 
 
Display Size X Age + Group X Age 3185.1 2.9 0.06 
 
Display Size X Age + Display Size X Group 3185.7 3.5 0.04 
      
 
Conjunction search 
  Generating model: Display Size X Age X Group 
Random effects structure: (1 + Display Size | Participant) 
  
Display Size X Age + Group X Age 5539.5 0.0 0.19 
 
Display Size + Age X Group 5539.5 0.0 0.19 
Display Size X Age + Group 5540.2 0.8 0.13 
Display Size + Age + Group 5540.3 0.8 0.13 
Display Size X Age + Group X Age + Display Size X Group 5541.3 1.8 0.08 
 
Display Size X Age X Group 5543.1 3.6 0.03 
     Boston Naming Test 
Generating model: Age X Group 
      Age 560.5 0.0 1.00 
Age X Group 829.3 268.8 0.00 
 
British Picture Vocabulary Scale 
  
  
Generating model: Age X Group 
  
      Age X Group 829.3 0.0 0.53 
Age + Group 830.0 0.7 0.38 
Age 833.0 3.6 0.09 
 
Group 1004.8 175.5 0.00 
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Fixation dwell time 
  
Generating model: Condition X Age2  X Group  
  
Random effects structure:  (1|Participant) 
  
  
Condition X Age2 + Age2 X Group + Condition X Group 16713.0 0.0 0.52 
Condition X Age2  X Group  16714.1 1.2 0.29 
Condition X Age
2
 +  Condition X Group 16715.0 2.1 0.18 
 
Condition X Age2 + Age2 X Group 16721.7 8.8 0.01 
Intrusive saccades 
  
Generating model: Condition X Age
2
 X Group 
  Random effects structure: (1|Participant) 
      
Condition X Age2 + Group 1734.9 0.0 0.29 
Condition X Age
2
 + Condition X Group 1735.1 0.3 0.26 
 
Condition X Age2 + Age2 X Group 1736.0 1.1 0.17 
Condition X Age2 + Age2 X Group + Condition X Group 1736.1 1.2 0.16 
Condition X Age
2
  X Group 1738.2 3.3 0.06 
 
Saccade onset 
  
  
Generating model:  Condition X Age X Group 
  Random effects structure: (1|Participant) 
Condition X Age + Condition X Group -977.0 0.0 0.58 
Condition X Age + Age X Group + Condition X Group -975.0 2.0 0.21 
 
Condition X Age -972.8 4.2 0.07 
     Saccade velocity 
Generating model:  Condition X Age X Group 
Random effects structure:  (1|Participant) 
Condition X Age 15446.6 0.0 0.63 
 
Condition X Age + Group 15448.5 2.0 0.24 
 
Condition X Age + Age X Group 15450.2 3.7 0.10 
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Appendix 3.  Tyrosinemia III model results. 
Model 
AIC ∆AIC 
Akaike 
Weight 
     Simple RT 
Generating model: Condition X Age
2
  X Group  
Random effects structure: (1|Participant) 
      
  
Condition X Age2  X Group  -422.1 0.00 0.45 
Age
2
 + Group  -420.1 1.97 0.17 
Age
2
 + Group + Condition -419.5 2.60 0.12 
Age2 X Group  -418.5 3.63 0.07 
     
 
Feature search 
  Generating model: Display Size X Age X Group 
Random effects structure: (1 + Display Size|Participant) 
  
Age X Group 3232.2 0.0 0.29 
 
Group X Age + Display Size X Group 3233.1 0.9 0.18 
Display Size + Group X Age 3233.2 1.1 0.17 
Display Size X Age + Group X Age + Display Size X Group 3233.7 1.6 0.13 
Display Size X Age + Group X Age  3233.8 1.6 0.13 
 
Display Size X Age X Group 3235.4 3.2 0.06 
     Conjunction search 
Generating model: Display Size X Age X Group 
Random effects structure: (1 + Display Size|Participant) 
      
  
Display Size + Age + Group 5565.7 0.00 0.18 
Display Size + Age X Group 5565.8 0.07 0.17 
Display Size X Age + Group 5566.5 0.81 0.12 
Display Size X Age + Group X Age 5566.6 0.87 0.11 
 
Display Size X Group + Age 5567.2 1.47 0.09 
 
Group X Age + Display Size X Group 5567.2 1.52 0.08 
Display Size + Age 5568.0 2.29 0.06 
Display Size X Age + Group X Age + Display Size X Group 5568.0 2.31 0.06 
Display Size X Age X Group 5568.7 2.97 0.04 
 
Display Size X Age 5568.8 3.08 0.04 
     Boston Naming Test 
Generating model: Age X Group 
  
Age X Group 532.6 0.0 0.93 
 
Age + Group 537.8 5.2 0.07 
Age 566.4 33.8 0.00 
Group 593.9 61.4 0.00 
 
British Picture Vocabulary Scale 
  
  
Generating model: Age X Group 
  
Age X Group 807.3 0.0 0.93 
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Age + Group 812.5 5.2 0.07 
Age 876.6 69.3 0.00 
Group 975.7 168.4 0.00 
 
Fixation dwell time 
  
  
Generating model: Condition X Age2  X Group  
  Random effects structure:  (1|Participant) 
Condition X Age2 +  Condition X Group 16009.9 0.0 0.34 
 
Condition X Age2 X Group  16010.2 0.3 0.29 
 
Condition X Age2 +  Group 16011.2 1.3 0.18 
Condition X Age
2
 + Age
2
 X Group + Condition X Group 16011.9 2.0 0.13 
Condition X Age
2
 + Age
2
 X Group 16013.2 3.3 0.07 
 
Intrusive saccades 
  
  
Generating model: Condition X Age2 X Group 
  Random effects structure: (1|Participant) 
Condition X Age2 + Age2 X Group 1645.5 0.0 0.29 
 
Condition X Age2 1645.6 0.0 0.28 
 
Condition X Age2 X Group  1646.9 1.4 0.15 
Condition X Age
2
 +  Group 1647.4 1.9 0.11 
Age
2
 +  Condition 1649.2 3.7 0.05 
 
Saccade onset 
  
  
Generating model:  Condition X Age X Group 
  Random effects structure: (1|Participant) 
Condition X Age -975.4 0.0 0.51 
 
Condition X Age + Group -974.1 1.3 0.26 
 
Condition X Age + Age X Group -972.1 3.3 0.10 
Saccade velocity 
Generating model:  Condition X Age X Group 
  
Random effects structure:  (1|Participant) 
  
      Condition X Age + Condition X Group 15455.0 0.0 0.36 
Condition X Age 15455.8 0.8 0.24 
Condition X Age + Group 15456.2 1.2 0.19 
 
Condition X Age + Age X Group + Condition X Group 15457.0 2.0 0.13 
 
Condition X Age + Age X Group 15458.2 3.2 0.07 
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